Chronic myeloid leukemia : biology and treatment
Material type:
TextLanguage: English Publication details: London : Martin Dunitz Ltd, 2001. Description: xv, 528 pagesISBN: 9781853178900Subject(s): Acute myeloid leukemiaDDC classification: 616.155.392 Online resources: Reviews Summary: Tremendous advances have been made in our understanding of the molecular mechanisms involved in human disease, and it can be argued that in this context chronic myeloid leukaemia is perhaps the best understood of all human malignancies. This text, from a world-renowned team of experts in CML, examines these advances and the implications they have for the management of this disease. Topics covered include the molecular and cellular biology of CML, conventional chemotherapy and interferon therapy, and recent developments in allografting and autografting. The book concludes with an overview of novel target-directed therapies, particularly the recent results with the tyrosine kinase inhibitor, STI571. This comprehensive text will be essential reading for all haemato-oncologists involved in this field.
| Item type | Current library | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|
Book
|
NISER LIBRARY | 616.155.392 CAR-C (Browse shelf(Opens below)) | Available | 25718 |
Includes bibliographical references and index.
Tremendous advances have been made in our understanding of the molecular mechanisms involved in human disease, and it can be argued that in this context chronic myeloid leukaemia is perhaps the best understood of all human malignancies. This text, from a world-renowned team of experts in CML, examines these advances and the implications they have for the management of this disease. Topics covered include the molecular and cellular biology of CML, conventional chemotherapy and interferon therapy, and recent developments in allografting and autografting. The book concludes with an overview of novel target-directed therapies, particularly the recent results with the tyrosine kinase inhibitor, STI571. This comprehensive text will be essential reading for all haemato-oncologists involved in this field.
There are no comments on this title.